Results 61 to 70 of about 249,531 (314)

An introspection of quality of novel drug approvals by United States Food and Drug Administration

International Journal of Basic & Clinical Pharmacology, 2018
Background: United States Food and Drug Administration (FDA) is the fastest drug review agency in the world. FDA is responsible for protection of the public health by assuring that foods are safe, wholesome, sanitary and properly labelled. Approved Novel drugs are often innovative products that serve unmet medical needs or otherwise help to advance ...
Rekha Mehani, Ajay K. Shukla
openaire   +2 more sources

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Investigation of Two Outbreaks of Hepatitis A Virus Infections Linked to Fresh and Frozen Strawberries Imported from Mexico – 2022–2023

Journal of Food Protection
Foodborne hepatitis A illnesses and outbreaks have been associated with the consumption of ready-to-eat foods contaminated with the feces of person(s) shedding hepatitis A virus (HAV).
Monica McClure, Margaret Kirchner, Tiffany Greenlee, Sharon Seelman, Asma Madad, Johnson Nsubuga, Ana Lilia Sandoval, Timothy Jackson, Mary Tijerina, Grace Tung, Kurt Nolte, Alexandre J. da Silva, Jeffrey Read, Vanessa Noelte, Jacquelina Woods, Angela Swinford, Jessica L. Jones, Melanie LaGrossa, Crystal McKenna, Efstathia Papafragkou, Christine Yu, Oliver Ou, Megan G. Hofmeister, Christina R. Samuel, Robin Atkinson, Monica To, Alison Orr, Joyce Cheng, Jamie Borlang, Katherine Lamba, Brandon Adcock, Christian Bond, Michael Needham, Summer Adams, Genny Grilli, Laurie K. Stewart, Tasha Martin, Julie Wagendorf, Danni Pinnick, Erin Smilanich, Alida Sorenson, Augustina Manuzak, Monique Salter, Alvin Crosby, Stelios Viazis   +44 more
doaj   +1 more source

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source

Structural insights into cannabinoid receptors CB1 and CB2: determinants of ligand selectivity

Frontiers in Chemical Biology
Cannabinoid receptors 1 (CB1) and 2 (CB2) are key components of the endocannabinoid system and play central roles in regulating diverse physiological processes, including neural signaling, immune modulation, and inflammation. Both receptors belong to the
Ann Varghese, Jie Liu, Wenjing Guo, Tucker A. Patterson, Huixiao Hong   +4 more
doaj   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source

Cosmetics.

, 1981
At head of title, Apr. 1978-Mar. 1980-: Pocket supplement to preamble compilation.Apr. 1978-Mar. 1980.Title from cover.Mode of access: Internet.Supplement to: United States. Food and Drug Administration.
United States. Food and Drug Administration
core  

Food Safety: Overview of Food Safety and Inspection Service and Food and Drug Administration Expenditures [PDF]

, 2000
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congressional request, GAO discussed food safety expenditures by the Food Safety and Inspection Service (FSIS) and the Food and Drug Administration (FDA ...
United States. General Accounting Office.
core  

Medical devices.

, 1981
Apr. 1978-Mar. 1980.At head of title, Apr. 1978-Mar. 1980-: Pocket supplement to preamble compilation.Title from cover.Mode of access: Internet.Supplement to: United States. Food and Drug Administration.
United States. Food and Drug Administration
core  

Import and export requirements and procedures Venezuela-United States [PDF]

, 2002
Plan BThe main objective of this paper is to present a general information on the issues involved in exporting and importing fresh vegetables from Venezuela to United States or vice versa.
Lanz, Jose I.
core